Tatalaksana Status Epileptikus di Instalasi Gawat Darurat
DOI:
https://doi.org/10.55175/cdk.v45i11.702Keywords:
Epilepsi, serangan, obat antiepilepsi, status epileptikusAbstract
Status epileptikus merupakan suatu kondisi kegawatdaruratan neurologis dengan morbiditas dan mortalitas tergantung durasi bangkitan. Tujuan terapi status epileptikus adalah penghentian segera aktivitas serangan agar mengurangi kematian dan kesakitan. Pedoman saat ini merekomendasikan benzodiazepin sebagai terapi lini pertama, fosfenitoin, asam valproat dan levetirasetam sebagai terapi lini kedua, serta agen anestesi sebagai terapi lini ketiga.
Status epilepticus is a neurologic emergency with morbidity and mortality that depends on the duration of seizures. The goal of status epilepticus therapy is immediate cessation of seizure activity which will reduce mortality and morbidity. Current guideline recommend the use of benzodiazepines as first-line therapy, phosphenitoin, valproic acid and levetiracetam as second-line therapy and anesthetic agents as thirdline therapy
Downloads
References
Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care. 2014;20(3):476–83.
Betjemann JP, Josephson SA, Lowenstein DH, Burke JF. Trends in status epilepticus—related hospitalizations and mortality: redefined in US practice over time. JAMA Neurol. 2015;72(6):650.
Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48–61.
Perhimpunan Dokter Spesialis Saraf Indonesia. Panduan praktik klinis neurologi. Kurniawan M, Suharjanti I, Pinzon RT, eds. Jakarta: Perhimpunan Dokter Spesialis Saraf Indonesia; 2016.
Pokdi Epilepsi Perdossi. Pedoman tatalaksana epilepsi. 5 ed. Kusumastuti K, Gunadharma S, Kustiowati E, eds. Surabaya: Airlangga University Press; 2014.
Fountain N, Lothman E. Pathophysiology of status epilepticus. J Clin Neurophysiol. 1995;12(4):326–42.
Aminoff MJ, Greenberg DA, Simon RP. Clinical Neurology. 9 ed. New York: McGraw Hill Education; 2015.
Louis ED, Mayer SA, Rowland LP. Merritt’s neurology. 13 ed. New York: Lippincott Williams & Wilkins; 2016.
Claassen J, Hirsch LJ, Kreiter KT, Du EY, Sander Connolly E, Emerson RG, dkk. Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol. 2004;115(12):2699–710.
Hantus S. Epilepsy emergencies: Contin Lifelong Learn Neurol. 2016;22(1):173–90.
Gilad R, Izkovitz N, Dabby R, Rapoport A, Sadeh M, Weller B, et al. Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand. 2008;118(5):296–300.
Misra UK, Kalita J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol. 2011;259:645–8.
DeToledo J, Ramsay R. Fosphenytoin and phenytoin in patients with status epilepticus: Improved tolerability versus increased costs. Drug Saf. 2000;22(6):459–66.
Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review. Epilepsia. 2002;43(2):146–53.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 https://creativecommons.org/licenses/by-nc/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
